REQUEST A DEMO
Total
USD $0.00
Search more companies

Cytopeutics Sdn. Bhd. (Malaysia)

Main Activities: Administration of Public Health Programs
Full name: Cytopeutics Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Cytopeutics Sdn. Bhd. is based in Malaysia. The head office is in Cyberjaya. The company operates in the Administration of Public Health Programs industry. The company was established on June 06, 2007. The latest financial highlights indicate a net sales revenue increase of 28.69% in 2024. Over the same period, its total assets decreased by 26.43%. In 2024, Cytopeutics Sdn. Bhd.’s net profit margin increased by 23.79%.

Headquarters
Suite 2-3, 2Nd Floor, Bio X Centre, Persiaran Cyberpoint Selatan, Cyber 8
Cyberjaya; Selangor; Postal Code: 63000

Contact Details: Purchase the Cytopeutics Sdn. Bhd. report to view the information.

Website: http://www.cytopeutics.com

Basic Information
Registered Capital:
Purchase the Cytopeutics Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Cytopeutics Sdn. Bhd. report to view the information.
Incorporation Date:
June 06, 2007
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
11.35%
Purchase this report to view the information.
8.25%
Purchase this report to view the information.
8.25%
Purchase this report to view the information.
8.25%
Subsidiaries
Cellavie Sdn. Bhd.
100%
Elixir Biotech Sdn. Bhd.
88%
Company Performance
Financial values in the chart are available after Cytopeutics Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
28.69%
Total Operating Revenue
28.69%
Operating Profit
814.08%
EBITDA
814.08%
Net Profit/Loss for the Period
1503.7%
Total Assets
-26.43%
Total Equity
-28.53%
Operating Profit Margin
22.23%
Net Profit Margin
23.79%
Return on Equity (ROE)
88.35%
Quick Ratio
-1.75%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?